Vir Biotechnology Inc (VIR) Stock Analysis

Vir Biotechnology Inc (VIR) is a publicly traded company in the HEALTHCARE sector. It trades at $8.74, carries a market capitalization of $1.52B. This page summarizes the public market data, fundamentals, and frequently asked questions for VIR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Vir Biotechnology Inc currently has a Neutral sentiment score of 0.02.

About Vir Biotechnology Inc

Vir Biotechnology, Inc. is a clinical-stage immunology company headquartered in San Francisco, California, focused on leveraging its proprietary technologies to develop therapeutic solutions for serious infectious diseases. With a robust pipeline targeting viral pathogens, including its innovative monoclonal antibodies and immunotherapeutics, Vir aims to address unmet medical needs in areas such as COVID-19 and influenza. The company's strategic partnerships and collaborations enhance its res...

GNG Research Analysis

GNG Research scores Vir Biotechnology Inc (VIR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for VIR.

Frequently Asked Questions

Does VIR pay dividends?

Vir Biotechnology Inc (VIR) does not currently pay a regular dividend.

What is VIR's market cap?

Vir Biotechnology Inc (VIR) has a market capitalization of $1.52B with a current stock price of $8.74.